The latest round of tests come as the U.S. dairy industry continues to battle the outbreak of HPAI H5N1 in cows ... “It is actually expected that RNA will remain in the milk after pasteurization.

This polymerase would need to switch from working well with bird proteins to working well with human ones. It has done that, to some extent: Some versions of H5N1 have acquired relevant mutations ...

Arcturus Therapeutics Holdings has won U.S. Food and Drug Administration fast-track designation for its ARCT-2304 pandemic flu vaccine candidate.

As highly pathogenic H5N1 avian influenza continues to spread ... Scientists previously had to use slower detection methods ...

Arcturus Therapeutics Receives U.S. FDA Fast Track Designation for the STARR® mRNA Vaccine Candidate ARCT-2304 for Pandemic Influenza A Virus H5N1 Arcturus Therapeutics Holdings Inc. (the ...

A study in Ontario found no traces of influenza A viral ribonucleic acid (RNA) in 117 samples of pasteurized retail milk collected in April and May 2024, ...

SAN DIEGO--(BUSINESS WIRE)-- Arcturus Therapeutics Holdings Inc. (ARCT), a commercial messenger RNA medicine company ... disease caused by influenza A H5N1 subtype contained in the vaccine.